The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Foamix announced the FDA has accepted for review the NDA for FMX103 topical foam.
read more
Spring Bank announced interim top-line results from the Phase 2 trial evaluating escalating doses inarigivir co-administered with Gilead Sciences’ ...
read more
Thursday, October 17, 2019
Bird Rock Bio announced the successful completion of their nimacimab study and the planned submission of an IND application to the FDA for a study in ...
read more
Wednesday, October 16, 2019
The NIDA has awarded a grant to EicOsis to support human clinical trials of a novel compound that has been found effective for the treatment of pain ...
read more
Wednesday, October 16, 2019
The GPC is partnering with AAN to develop a core set of outcomes to be used in pivotal and late phase clinical trials of therapies for moderate to ...
read more
Wednesday, October 16, 2019
Denovo Biopharma has announced FDA's approval to initiate a Phase 2b clinical study of DB102 in patients with newly-diagnosed glioblastoma in ...
read more
Tuesday, October 15, 2019
Innoveix Pharmaceuticals is voluntarily recalling all sterile compounded drug products, within expiry, to the consumer level.
read more
Tuesday, October 15, 2019
Therapix Biosciences announced positive results in its pre-clinical study evaluating THX-210, a proprietary novel pharmaceutical preparation ...
read more
Tuesday, October 15, 2019
AFTD and Target ALS announced a partnership and call for proposals to identify treatments and biomarkers for FTD and ALS.
read more
Kodiak Sciences announced the first patients have been treated in the study of KSI-301 in patients with treatment-naïve wet AMD.
read more
The FDA has awarded 12 new clinical trial research grants totaling more than $15 million over the next four years to enhance the development of ...
read more
Thursday, October 10, 2019
Avacta Group has entered a collaboration and option agreement with ADC Therapeutics to develop Affimer-drug conjugates.
read more
Thursday, October 10, 2019
Janssen Research & Development
Neumentum has entered into a global licensing agreement with Janssen and McNeil Consumer Pharmaceuticals for the rights to a novel oral analgesic.
read more
Tuesday, October 08, 2019
VistaGen announced the last patient has completed dosing in the ELEVATE Phase 2 clinical study of AV-101, as an adjunctive treatment for major ...
read more
Thursday, October 03, 2019
NeuroCycle has been awarded a grant from the NIH HEAL Initiativesm, to advance development of its novel non-addictive treatment of chronic ...
read more